I’ll guess that there’s no literature on the subject.
FDA rules require a lot more work per patient for trials. I’m guessing something like $10k per patient, so you’re likely proposing more than a trillion dollars in spending. And that assumes there are no problems with hiring and training enough people to run the trials.
Given that the US government typically values the life of an individual at around $10 million, you only need to save 100,000 US lives to make that worthwhile. We’ve lost triple that number in this pandemic. Certainly it would be logistically complex, but we have to compare the logistical complexity of running that kind of trial with the current complexities we face.
I’ll guess that there’s no literature on the subject.
FDA rules require a lot more work per patient for trials. I’m guessing something like $10k per patient, so you’re likely proposing more than a trillion dollars in spending. And that assumes there are no problems with hiring and training enough people to run the trials.
Given that the US government typically values the life of an individual at around $10 million, you only need to save 100,000 US lives to make that worthwhile. We’ve lost triple that number in this pandemic. Certainly it would be logistically complex, but we have to compare the logistical complexity of running that kind of trial with the current complexities we face.